LynceiSign in
Demo version of Lyncei. People, studies and DOIs are fictional; anyone can sign in to the demo accounts.
Back to feed
Dr. Jonah ParkOncology
1d
Visual

Updated meta-analysis on neoadjuvant immunotherapy in early-stage NSCLC

Event-free survival improves across trials; overall survival data are still maturing.

[Demo] Neoadjuvant immunotherapy in resectable NSCLC: an updated meta-analysisDemo Oncology Reviews · 2026doi:10.5555/demo.nsclc.2026
Does neoadjuvant immunotherapy improve survival in early-stage NSCLC?
Expert review in progress1 of 2
000
Rigor
Source-linked
A source is linked. No one has checked the interpretation yet. Reach (likes, shares) never changes this label.

Reviews (2)

A source is linked. No one has checked the interpretation yet.

Dr. Marcus Lee · Biostatistics
Completed
Methodological assessment · Sound

Search strategy is comprehensive and heterogeneity is explored appropriately.

  • Risk of bias is addressed
  • Design is appropriate for the question
Signed review · Conflicts: None declared · Reviewed version 1 · 23h ago
Dr. Amira Khalil · Internal Medicine
In progress
Statistical review

Review underway.

Signed review · Conflicts: None declared · Reviewed version 1

Discussion (0)

Sign in to join the discussion.

Start the discussion with a question or evidence.